All resources are organized into categories. Click the arrow to reveal the subcategories within each category. Click any category or subcategory to view all the resources it contains.
Text search
Enter words or phrases to search for resources. Note: This searches on the resource titles and descriptions, but does not currently search the content of the resources (e.g., the text in a PDF).
Advanced Search
Tick the boxes to search any combination of category, resource format, author, publication date, and whether a resource is peer reviewed or available in French. As you check and uncheck items, the count of matching resources will update. Click the blue “SHOW RESULTS” button to view resources that match the criteria you have selected.
This Making Self-Injection Count workshop session provided an overview of self-injection indicators across countries and how those can be integrated into HMIS/LMIS systems and analyzed to answer programmatic and research questions. Stories from Uganda and Nigeria highlighted common challenges in integrating self-injection indicators into these systems. Breakout rooms at the end of the session allowed participants to discuss and receive suggestions and feedback on their own HMIS/LMIS integration efforts through peer-to-peer conversations.
Objectives
By the end of this session, participants were able to:
Identify common self-injection indicators, challenges in integrating these indicators into HMIS/LMIS systems, and potential strategies for overcoming them.
Have a deeper understanding of how to match common self-injection HMIS indicators to programmatic and/or research questions and how to translate those to actionable data.
Key takeaways
Self-injection introduction into a national family planning program can help expand contraceptive choices and options.
To continuously monitor the unique contribution of self-injection to the family planning program, routine data are necessary.
Self-injection data use helps to inform decision-making through the identification of policy and programmatic gaps, such as:
Number of units for training, approval for specific cadres of providers, need for better counseling messages and tools.
Data and indicators to integrate in HMISes must be useful and usable.
There is benefit to complementing routine data with other from additional sources, e.g., research studies or surveys.
A proactive government is vital to the success of self-injection data integration.
Competing priorities and limited funding are perennial challenges to integrating self-injection in HMIS data.
This opening plenary of the Making Self-Injection Count workshop highlighted how self-injection data can help close the gender data gap by providing key information and insights on the experiences of women and adolescents. Presenters discussed how self-injection can contribute to contraceptive autonomy by enabling women and girls to make and actualize their own decisions. The session featured personal stories from a self-injection ambassador, self-injection provider, and self-injection client.
Objectives
By the end of this session, participants were able to:
Describe the importance of self-injection for contraceptive autonomy, and self-injection in the context of self-care.
Describe the landscape of self-injection data availability.
Understand experiences of self-injection from the lens of a provider, user, and advocate.
Key takeaways
While progress is being made, self-injection data availability is still limited compared to other contraceptive data sets.
Disaggregation by client age, district, and DMPA-SC delivery mode (self-injected vs. provider-administered DMPA-SC) is essential to DMPA-SC data tracking.
High-quality data systems give us insight into women’s and girls’ preferences, client access to family planning, provider training needs, and global supply management opportunities.
The Family Planning Financing Roadmap is a resource for USAID Mission staff and others working on family planning issues in developing countries. The website is designed to support sustainable family planning approaches for a wide range of users, from those who have very limited knowledge of health financing concepts to those who have some knowledge or experience and are looking to develop a deeper understanding of specific issues. The website has three main sections: learning materials, an interactive roadmap, and a community of practice.
The Contraceptive Technology Innovation (CTI) Exchange is a platform for increasing global access to resources on contraceptive research, development, registration, and introduction through collaboration and knowledge sharing. The site features Calliope, the Contraceptive Pipeline Database, which provides information on new and future contraceptive products, including long-acting and novel products currently only available in limited markets.
The Track20 Project, implemented by Avenir Health, monitors progress towards achieving the goals of the global FP2020 initiative, adding an additional 120 million modern method users between 2012 and 2020 in the world’s 69 poorest countries. Track20 works directly with governments in participating FP2020 countries to collect, analyze and use data to monitor progress annually in family planning and to actively use data to improve family planning strategies and plans. Track20 activities and efforts are focused on countries that chose to make a commitment to the FP2020 global initiative, referred to as Track20 Focus Countries. The remaining FP2020 countries, referred to as Additional Track20 Countries, will also receive some technical support.
Institutional author(s): Avenir Health
Publication date: 2021
The G-FINDER project tracks annual investment in research and development for new products and technologies that are designed to address the persistent global health challenges that disproportionately affect the world’s most disadvantaged people. The project’s goal is to provide funders, policy makers, researchers, advocates, journalists and others with an accurate understanding of the research and development funding landscape for neglected diseases and other global health priorities. The G-FINDER data portal provides open access to all of the underlying data captured by the G-FINDER survey every year since 2007.
PMA generates frequent, high-quality surveys monitoring key health indicators in nine countries in Africa and Asia. Data is available open-source for research, program planning, and policy-making. PMA family planning briefs provide a snapshot of select indicators through charts, graphs and tables. Key indicators for family planning include unmet need for family planning, modern contraceptive prevalence rate (mCPR), and family planning access, equity, quality, and choice.
The Reproductive Health Supplies Visualizer (RH Viz) is a series of public-facing dashboards designed to help the RH community see integrated and aggregated supply chain inventory, order, and shipment data.
The Global Family Planning Visibility and Analytics Network (VAN) captures data from multiple sources to improve supply chain visibility. The VAN offers a platform to assess supply needs, prioritize them, and act when supply imbalances loom.
The ExpandNet bibliography includes publications, websites, grey literature, and conference reports that either directly address scaling up or provide valuable insights on scaling up. Included are materials from a range of global health and development technical areas as well as the various sciences relevant to scale up.
